Results
|
|
981.
|
Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial. [electronic resource] by
- Cho, Kyu Yong
- Nakamura, Akinobu
- Omori, Kazuno
- Takase, Takahiro
- Miya, Aika
- Manda, Naoki
- Kurihara, Yoshio
- Aoki, Shin
- Atsumi, Tatsuya
- Miyoshi, Hideaki
Producer: 20200203
In:
Diabetes, obesity & metabolism vol. 21
Availability: No items available.
|
|
|
982.
|
|
|
|
983.
|
|
|
|
984.
|
|
|
|
985.
|
|
|
|
986.
|
|
|
|
987.
|
|
|
|
988.
|
|
|
|
989.
|
|
|
|
990.
|
|
|
|
991.
|
|
|
|
992.
|
|
|
|
993.
|
|
|
|
994.
|
|
|
|
995.
|
|
|
|
996.
|
|
|
|
997.
|
|
|
|
998.
|
|
|
|
999.
|
|
|
|
1000.
|
|